CN Patent
CN100469765C — 前列腺素硝基氧衍生物
Assigned to Nicox SA · Expires 2009-03-18 · 17y expired
What this patent protects
描述了具有改善的药理学活性和提高的耐受性的前列腺素硝基氧衍生物。它们可以用于治疗青光眼和高眼压。
USPTO Abstract
描述了具有改善的药理学活性和提高的耐受性的前列腺素硝基氧衍生物。它们可以用于治疗青光眼和高眼压。
Drugs covered by this patent
- Vyzulta (LATANOPROSTENE BUNOD) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.